Gallstone disease: Primary and secondary prevention

Area of Science:

• Gastroenterology
• Hepatology
• Preventive Medicine

Background:

• Cholesterol gallstone formation is linked to factors like prolonged fasting, rapid weight loss, and certain medical treatments.
• The risks of biliary colic and complications in asymptomatic gallstone carriers are not well-established.
• Existing treatments like ursodeoxycholic acid (UDCA) and prophylactic cholecystectomy are proposed for gallstone carriers but lack robust clinical trial data.

Purpose of the Study:

• To review strategies for preventing gallstone formation in the general population and high-risk groups.
• To discuss methods for preventing biliary colic and gallstone complications in both asymptomatic and symptomatic gallstone carriers.

Main Methods:

• This study is a literature review.
• It synthesizes existing evidence on gallstone prevention and management strategies.
• It identifies gaps in current research, particularly the need for randomized controlled trials.

Main Results:

• Identified risk factors for gallstone formation include prolonged fasting, rapid weight loss, total parenteral nutrition, and somatostatin analogue treatment.
• Ursodeoxycholic acid (UDCA) and prophylactic cholecystectomy are suggested for gallstone carriers to reduce complications.
• A significant lack of randomized, double-blind, placebo-controlled trials was noted for these interventions.

Conclusions:

• Evidence-based strategies are needed for gallstone prevention in at-risk populations.
• Further research, including high-quality clinical trials, is crucial to validate the efficacy of UDCA and prophylactic cholecystectomy.
• Optimal management of asymptomatic and symptomatic gallstone carriers requires more robust scientific support.